Structure based design of macrocyclic factor XIa inhibitors: Discovery of cyclic P1 linker moieties with improved oral bioavailability

被引：11

作者：

Clark, Charles G. ^{[1
]}

Rossi, Karen A. ^{[1
]}

Corte, James R. ^{[1
]}

Fang, Tianan ^{[1
]}

Smallheer, Joanne M. ^{[1
]}

De Lucca, Indawati ^{[1
]}

Nirschl, David S. ^{[1
]}

Orwat, Michael J. ^{[1
]}

Pinto, Donald J. P. ^{[1
]}

Hu, Zilun ^{[1
]}

Wang, Yufeng ^{[1
]}

Yang, Wu ^{[1
]}

Jeon, Yoon ^{[1
]}

Ewing, William R. ^{[1
]}

Myers, Joseph E., Jr. ^{[1
]}

Sheriff, Steven ^{[1
]}

Lou, Zhen ^{[1
]}

Bozarth, Jeffrey M. ^{[1
]}

Wu, Yiming ^{[1
]}

Rendina, Alan ^{[1
]}

Harper, Timothy ^{[1
]}

Zheng, Joanna ^{[1
]}

Xin, Baomin ^{[1
]}

Xiang, Qian ^{[1
]}

Luettgen, Joseph M. ^{[1
]}

Seiffert, Dietmar A. ^{[1
]}

Wexler, Ruth R. ^{[1
]}

Lam, Patrick Y. S. ^{[1
]}

机构：

[1] Bristol Myers Squibb Co, POB 4000, Princeton, NJ 08543 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2019年 / 29卷 / 19期

关键词：

Factor XIa inhibitors; FXIa; Activated partial thromboplastin time; aPTT; Thrombosis; Anticoagulant; Bioavailability; COAGULATION-FACTOR XIA; SMALL-MOLECULE; BLEEDING-TIME; DISEASE; POTENT;

D O I：

10.1016/j.bmcl.2019.08.008

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

This manuscript describes the discovery of a series of macrocyclic inhibitors of FXIa with oral bioavailability. Assisted by structure based drug design and ligand bound X-ray crystal structures, the group linking the P1 moiety to the macrocyclic core was modified with the goal of reducing H-bond donors to improve pharmacokinetic performance versus 9. This effort resulted in the discovery of several cyclic P1 linkers, exemplified by 10, that are constrained mimics of the bioactive conformation displayed by the acrylamide linker of 9. These cyclic P1 linkers demonstrated enhanced bioavailability and improved potency.

引用

页数：7

共 18 条

[1] Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis [J].

Bueller, Harry R. ;

Bethune, Claudette ;

Bhanot, Sanjay ;

Gailani, David ;

Monia, Brett P. ;

Raskob, Gary E. ;

Segers, Annelise ;

Verhamme, Peter ;

Weitz, Jeffrey I. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (03) :232-240

[2] ENANTIOSELECTIVE AND PRACTICAL SYNTHESES OF R-FLUOXETINE AND S-FLUOXETINE [J].

COREY, EJ ;

REICHARD, GA .

TETRAHEDRON LETTERS, 1989, 30 (39) :5207-5210

[3] Macrocyclic inhibitors of Factor XIa: Discovery of alkyl-substituted macrocyclic amide linkers with improved potency [J].

Corte, James R. ;

Yang, Wu ;

Fang, Tianan ;

Wang, Yufeng ;

Osuna, Honey ;

Lai, Amy ;

Ewing, William R. ;

Rossi, Karen A. ;

Myers, Joseph E., Jr. ;

Sheriff, Steven ;

Lou, Zhen ;

Zheng, Joanna J. ;

Harper, Timothy W. ;

Bozarth, Jeffrey M. ;

Wu, Yiming ;

Luettgen, Joseph M. ;

Seiffert, Dietmar A. ;

Quan, Mimi L. ;

Wexler, Ruth R. ;

Lam, Patrick Y. S. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (16) :3833-3839

[4] Structure-Based Design of Macrocyclic Factor XIa Inhibitors: Discovery of the Macrocyclic Amide Linker [J].

Corte, James R. ;

Fang, Tianan ;

Osuna, Honey ;

Pinto, Donald J. P. ;

Rossi, Karen A. ;

Myers, Joseph E., Jr. ;

Sheriff, Steven ;

Lou, Zhen ;

Zheng, Joanna J. ;

Harper, Timothy W. ;

Bozarth, Jeffrey M. ;

Wu, Yiming ;

Luettgen, Joseph M. ;

Seiffert, Dietmar A. ;

Decicco, Carl P. ;

Wexler, Ruth R. ;

Quan, Mimi L. .

JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (03) :1060-1075

[5] Orally bioavailable pyridine and pyrimidine-based Factor XIa inhibitors: Discovery of the methyl N-phenyl carbamate P2 prime group [J].

Corte, James R. ;

Fang, Tianan ;

Pinto, Donald J. P. ;

Orwat, Michael J. ;

Rendina, Alan R. ;

Luettgen, Joseph M. ;

Rossi, Karen A. ;

Wei, Anzhi ;

Ramamurthy, Vidhyashankar ;

Myers, Joseph E., Jr. ;

Sheriff, Steven ;

Narayanan, Rangaraj ;

Harper, Timothy W. ;

Zheng, Joanna J. ;

Li, Yi-Xin ;

Seiffert, Dietmar A. ;

Wexler, Ruth R. ;

Quan, Mimi L. .

BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (10) :2257-2272

[6] Factor XI as a Therapeutic Target [J].

Gailani, David ;

Gruber, Andras .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (07) :1316-+

[7] Upstream versus downstream thrombin inhibition [J].

Gulpen, Anouk J. W. ;

Ten Cate-Hoek, Arina J. ;

Ten Cate, Hugo .

EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2016, 14 (11) :1273-1282

[8] Phenylimidazoles as Potent and Selective Inhibitors of Coagulation Factor XIa with in Vivo Antithrombotic Activity [J].

Hangeland, Jon J. ;

Friends, Todd J. ;

Rossi, Karen A. ;

Smallheer, Joanne M. ;

Wang, Cailan ;

Sun, Zhong ;

Corte, James R. ;

Fang, Tianan ;

Wong, Pancras C. ;

Rendina, Alan R. ;

Barbera, Frank A. ;

Bozarth, Jeffrey M. ;

Luettgen, Joseph M. ;

Watson, Carol A. ;

Zhang, Ge ;

Wei, Anzhi ;

Ramamurthy, Vidhyashankar ;

Morin, Paul E. ;

Bisacchi, Gregory S. ;

Subramaniam, Srinath ;

Arunachalam, Piramanayagam ;

Mathur, Arvind ;

Seiffert, Dietmar A. ;

Wexler, Ruth R. ;

Quan, Mimi L. .

JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (23) :9915-9932

[9] Limitations of traditional anticoagulants [J].

Hawkins, D .

PHARMACOTHERAPY, 2004, 24 (07) :62S-65S

[10] Discovery of a Potent Parenterally Administered Factor XIa Inhibitor with Hydroxyquinolin-2(1H)-one as the P2′ Moiety [J].

Hu, Zilun ;

Wong, Pancras C. ;

Gilligan, Paul J. ;

Han, Wei ;

Pabbisetty, Kumar B. ;

Bozarth, Jeffrey M. ;

Crain, Earl J. ;

Harper, Timothy ;

Luettgen, Joseph M. ;

Myers, Joseph E., Jr. ;

Ramamurthy, Vidhyashankar ;

Rossi, Karen A. ;

Sheriff, Steven ;

Watson, Carol A. ;

Wei, Anzi ;

Zheng, Joanna J. ;

Seiffert, Dietmar A. ;

Wexler, Ruth R. ;

Quan, Mimi L. .

ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (05) :590-595

← 1 2 →